To test whether PGS also has an inhibitory effect on pSARS-CoV-2 entry, we treated ACE2+ and ACE2/TMPRSS2+ cells with serial threefold dilutions of PGS stock solution containing 15 mg/ml PG root for 1 h before infection with pSARS-CoV-2. The gene discussed is ACE2; the disease is infection.